Mixed results for Florida's biotech initiative

Florida's push to attract biotech business to the state is having mixed results. Several biotech institutes--Torrey Pines Institute for Molecular Studies, the Burnham Institute for Medical Research and The Scripps Research Institute--have been lured away to San Diego by generous incentive packages. In addition, the number of biotechs in Florida has grown from 48 in 2004 to 85 in 2006. But in order to stay competitive with other states, Florida is going to have to pour more money into economic development, to make up for its late entry into the field. Arizona in particular is shaping up as Florida's biggest competitor for biotech spending.

- read this article from the Palm Beach Post for more on the state's biotech push 

Suggested Articles

Galecto picked up $64 million to push its lead lung disease treatment toward an approval in Europe and fund midstage studies for its other programs.

The financing, which attracted support from Roche Venture Fund, sets Palladio up to test its vasopressin V2 receptor antagonist in a kidney disease.

A new atlas of 500,000 cardiac cells could help researchers better understand how a healthy heart operates—and what goes wrong in heart disease.